NASDAQ:ZLAB
Zai Lab Ltd Stock News
$21.01
+4.44 (+26.80%)
At Close: May 09, 2024
Zai Lab Announces Upcoming Presentations in October Investor Conferences
07:30am, Monday, 11'th Oct 2021
SHANGHAI and SAN FRANCISCO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that
SHANGHAI, China and SAN FRANCISCO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) partner Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company de
Final data collection is expected in the first half of 2022
Zai Lab Holds Virtual Research and Development Day
12:22pm, Wednesday, 22'nd Sep 2021
-- Expects to have more than 15 marketed products in more than 35 indications by 2025-- Aspires to become a leading global biopharmaceutical company
Zai Lab Expands U.S. Operations to Join the Cambridge Biotechnology Community
07:30am, Thursday, 16'th Sep 2021
SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, announced today that it will expa
Zai Lab Announces Breakthrough Therapy Designation Granted for Bemarituzumab (FPA144) in China
07:30am, Tuesday, 14'th Sep 2021
Potential first-in-class therapy for a subset of gastric and gastroesophageal (GEJ) cancers that overexpress fibroblast growth factor receptor 2 (FGFR2b) Potential first-in-class therapy for a subset
Zai Lab Announces Upcoming Presentations in September Investor Conferences
07:30am, Tuesday, 24'th Aug 2021
SHANGHAI and SAN FRANCISCO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that
Zai Lab Limited (ZLAB) CEO Samantha Du on Q2 2021 Results - Earnings Call Transcript
01:58pm, Tuesday, 10'th Aug 2021
Zai Lab Limited (ZLAB) CEO Samantha Du on Q2 2021 Results - Earnings Call Transcript
Zai Lab Announces Second Quarter 2021 Financial Results and Corporate Updates
04:30pm, Monday, 09'th Aug 2021
Company to Host Conference Call and Webcast on August 10, 2021, at 8:00 a.m. EDT Company to Host Conference Call and Webcast on August 10, 2021, at 8:00 a.m. EDT
Schrödinger, Zai Lab Team Up For Cancer Program Targeting DNA Damage Response
11:53am, Wednesday, 04'th Aug 2021
Schrödinger Inc (NASDAQ: SDGR) and Zai Lab Limited (NASDAQ: ZLAB) have collaborated to discover, develop, and commercialize oncology candidate targeting DNA damage response. The research program
Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology
07:30am, Wednesday, 04'th Aug 2021
Agreement provides Schrödinger and Zai Lab with pipeline expansion opportunities in precision oncology Agreement provides Schrödinger and Zai Lab with pipeline expansion opportunities in precision o
Reviewing Our Recent Zai Lab Limited Buy Recommendation
09:03pm, Friday, 30'th Jul 2021
As noted in Wall Street Breakfast "Even when you think China risk is priced, it can get worse" Recent Government actions prompt a new degree of caution in further advices; should we go to the point of
Zai Lab to Announce Second Quarter 2021 Financial Results
07:30am, Thursday, 22'nd Jul 2021
SHANGHAI and SAN FRANCISCO, July 22, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will report
Zai Lab: Best Now Capital Gain Biotech For Near-Term Wealth-Building, So Say Market-Makers
02:58pm, Sunday, 18'th Jul 2021
Like it or not, capital gain prospects for stocks in U.S. equities markets are all directly comparable with one another, and investors who want those gains need to make comparisons. The comparability
Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
12:44pm, Wednesday, 30'th Jun 2021
Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
